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Linear growth in the postnatal period is controlled by
the production, secretion, and action of pituitary growth
hormone and IGF-1. IGF-I and IGF-II production and
signaling are also essential for fetal growth and neural
development. But the control of IGF production in the
fetus is largely independent of GH.
Among the factors that control fetal IGF production, the
availability and utilization of nutrients is most important.
Since fetal nutrient supply ultimately derives from mater-
nal nutrient stores, we can understand fetal growth only
through analysis of the factors that control maternal nutri-
ent utilization and transport to the fetus.
I will argue that hormones produced by the placenta,
including placental lactogen, placental growth hormone,
and sex steroids regulate the intake, absorption, utilization
and transfer of maternal nutrients to the fetus and modu-
late fetal and neonatal insulin production. Dysregulation of
placental hormone production may be associated with fetal
growth retardation or fetal overgrowth and may predispose
in later life to glucose intolerance and type 2 diabetes.
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